Kymera Therapeutics KYMR Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$69.23M+20.4% | -$86.98M-5.8% | -$82.18M-7.3% | -$76.61M-16.8% | -$65.58M+7.3% | ||
| $2.02M-0.5% | $2.03M-5.4% | $2.15M+3.1% | $2.08M+1.8% | $2.05M+3.1% | ||
| $16.01M+10.8% | $14.45M-8.5% | $15.8M+2.5% | $15.42M+8.3% | $14.23M+3.1% | ||
| -$88.84M-33.1% | -$66.75M-146% | -$27.11M+54.7% | -$59.88M+24.3% | -$79.15M-28.1% | ||
| $434K+309% | $106K-41.4% | $181K-74.0% | $695K+48.8% | $467K-50.1% | ||
| -$142.84M+63.8% | -$394.4M-67.6% | -$235.3M-492% | $60.02M+23.5% | $48.62M— | ||
| $18.77M-97.3% | $705.22M+1,685% | $39.51M-83.9% | $245.73M+95,143% | $258K-90.7% | ||
| -$212.91M-187% | $244.07M+209% | -$222.9M-191% | $245.86M+912% | -$30.28M-417% | ||
| -$89.27M-33.5% | -$66.85M-145% | -$27.29M+54.9% | -$60.58M+23.9% | -$79.62M-26.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Kymera Therapeutics generate?
- Kymera Therapeutics (KYMR) generated -$242.6M in operating cash flow over the trailing twelve months.
- What is Kymera Therapeutics's free cash flow?
- After $1.4M of capital expenditures, Kymera Therapeutics's free cash flow was -$244.0M over the trailing twelve months, down 1.7% year over year.
- Where does Kymera Therapeutics's cash flow data come from?
- Every line is extracted from Kymera Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
